Publication list - Publika - Scientific publications from Oslo University Hospital

Publications by Mona-Elisabeth R. Revheim

118 publications found

Original articles

Evanson D, Griffin M, O'Reilly SE, Johnson T, Werner T, Kothekar E, Jahangiri P, Simone CB, Swisher-McClure S, Feigenberg SJ, Revheim ME, Zou J, Alavi A (2023)
Comparative assessment of radiation therapy-induced vasculitis using [¹⁸F]FDG-PET/CT in patients with non-small cell lung cancer treated with proton versus photon radiotherapy
Eur J Nucl Med Mol Imaging, 51 (5), 1444-1450
DOI 10.1007/s00259-023-06535-3, PubMed 38095673

Dahlberg D, Holm S, Sagen EML, Michelsen AE, Stensland M, de Souza GA, Müller EG, Connelly JP, Revheim ME, Halvorsen B, Hassel B (2023)
Bacterial Brain Abscesses Expand Despite Effective Antibiotic Treatment: A Process Powered by Osmosis Due to Neutrophil Cell Death
Neurosurgery, 94 (5), 1079-87 (in press)
DOI 10.1227/neu.0000000000002792, PubMed 38084989

Jenul A, Stokmo HL, Schrunner S, Hjortland GO, Revheim ME, Tomic O (2023)
Novel ensemble feature selection techniques applied to high-grade gastroenteropancreatic neuroendocrine neoplasms for the prediction of survival
Comput Methods Programs Biomed, 244, 107934
DOI 10.1016/j.cmpb.2023.107934, PubMed 38016391

Lysvik EK, Mikalsen LTG, Rootwelt-Revheim ME, Emblem KE, Hjørnevik T (2023)
Optimization of Q.Clear reconstruction for dynamic ¹⁸F PET imaging
EJNMMI Phys, 10 (1), 65
DOI 10.1186/s40658-023-00584-1, PubMed 37861929

Subtirelu RC, Teichner EM, Su Y, Al-Daoud O, Patel M, Patil S, Writer M, Werner T, Revheim ME, Høilund-Carlsen PF, Alavi A (2023)
Aging and Cerebral Glucose Metabolism: ¹⁸F-FDG-PET/CT Reveals Distinct Global and Regional Metabolic Changes in Healthy Patients
Life (Basel), 13 (10)
DOI 10.3390/life13102044, PubMed 37895426

Høilund-Carlsen PF, Revheim ME, Costa T, Kepp KP, Castellani RJ, Perry G, Alavi A, Barrio JR (2023)
FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer's Disease: Benefits and Pitfalls
Diagnostics (Basel), 13 (13)
DOI 10.3390/diagnostics13132254, PubMed 37443645

Reddy N, Raynor WY, Werner TJ, Baker JF, Alavi A, Revheim ME (2023)
¹⁸F-FDG and ¹⁸F-NaF PET/CT Global Assessment of Large Joint Inflammation and Bone Turnover in Rheumatoid Arthritis
Diagnostics (Basel), 13 (13)
DOI 10.3390/diagnostics13132149, PubMed 37443544

Larsen SG, Graf W, Mariathasan AB, Sørensen O, Spasojevic M, Goscinski MA, Selboe S, Lundstrøm N, Holtermann A, Revheim ME, Bruland ØS (2023)
First experience with ²²⁴Radium-labeled microparticles (Radspherin®) after CRS-HIPEC for peritoneal metastasis in colorectal cancer (a phase 1 study)
Front Med (Lausanne), 10, 1070362
DOI 10.3389/fmed.2023.1070362, PubMed 36936230

Grønningsæter SR, Blakkisrud J, Selboe S, Revheim ME, Bruland ØS, Bønsdorff TB, Larsen SG, Stokke C (2023)
Radiation safety considerations for the use of radium-224-calciumcarbonate-microparticles in patients with peritoneal metastasis
Front Med (Lausanne), 10, 1058914
DOI 10.3389/fmed.2023.1058914, PubMed 36844217

Mamidi RS, Ayubcha C, Rigney G, Kirschner J, Gerke O, Werner TJ, Tebas P, Alavi A, Revheim ME (2023)
A prospective 18 F-fluorodeoxyglucose positron emission tomography/computed tomography study of the neurometabolic effects in cocaine use and HIV infection
AIDS, 37 (6), 905-912
DOI 10.1097/QAD.0000000000003485, PubMed 36727840

Juzeniene A, Stenberg VY, Bruland ØS, Revheim ME, Larsen RH (2023)
Dual targeting with ²²⁴Ra/²¹²Pb-conjugates for targeted alpha therapy of disseminated cancers: A conceptual approach
Front Med (Lausanne), 9, 1051825
DOI 10.3389/fmed.2022.1051825, PubMed 36733936

Tornes AJK, Stenberg VY, Larsen RH, Bruland ØS, Revheim ME, Juzeniene A (2022)
Targeted alpha therapy with the ²²⁴Ra/²¹²Pb-TCMC-TP-3 dual alpha solution in a multicellular tumor spheroid model of osteosarcoma
Front Med (Lausanne), 9, 1058863
DOI 10.3389/fmed.2022.1058863, PubMed 36507500

Maggadóttir SM, Kvalheim G, Wernhoff P, Sæbøe-Larssen S, Revheim ME, Josefsen D, Wälchli S, Helland Å, Inderberg EM (2022)
A phase I/II escalation trial design T-RAD: Treatment of metastatic lung cancer with mRNA-engineered T cells expressing a T cell receptor targeting human telomerase reverse transcriptase (hTERT)
Front Oncol, 12, 1031232
DOI 10.3389/fonc.2022.1031232, PubMed 36439452

Langen Stokmo H, Aly M, Bowitz Lothe IM, Borja AJ, Mehdizadeh Seraj S, Ghorpade R, Miao X, Hjortland GO, Malinen E, Sorbye H, Werner TJ, Alavi A, Revheim ME (2022)
Volumetric parameters from [¹⁸ F]FDG PET/CT predicts survival in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms
J Neuroendocrinol, 34 (7), e13170
DOI 10.1111/jne.13170, PubMed 35729738

Stenberg VY, Tornes AJK, Nilsen HR, Revheim ME, Bruland ØS, Larsen RH, Juzeniene A (2022)
Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand ²¹²Pb-NG001
Cancers (Basel), 14 (11)
DOI 10.3390/cancers14112784, PubMed 35681766

Park PSU, Raynor WY, Khurana N, Sun Y, Werner TJ, Høilund-Carlsen PF, Alavi A, Revheim ME (2022)
Application of ¹⁸F-NaF-PET/CT in assessing age-related changes in the cervical spine
Quant Imaging Med Surg, 12 (6), 3314-3324
DOI 10.21037/qims-21-1174, PubMed 35655822

Zirakchian Zadeh M, Asadollahi S, Kaghazchi F, Raynor WY, Mehdizadeh Seraj S, Werner TJ, Seierstad T, Korostoff J, Swisher-McClure S, Alavi A, Revheim ME (2022)
Prognostic significance of conventional and volumetric PET parameters with and without partial volume correction in the assessment of head and neck squamous cell carcinoma
Nucl Med Commun, 43 (7), 800-806
DOI 10.1097/MNM.0000000000001573, PubMed 35552334

Stokke C, Nørgaard JN, Feiring Phillips H, Sherwani A, Nuruddin S, Connelly J, Schjesvold F, Revheim ME (2022)
Comparison of [¹⁸F]fluciclovine and [¹⁸F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients
Mol Imaging Biol, 24 (5), 842-851
DOI 10.1007/s11307-022-01734-0, PubMed 35501622

Løndalen A, Blakkisrud J, Revheim ME, Dahle J, Kolstad A, Stokke C (2022)
FDG PET/CT and Dosimetric Studies of ¹⁷⁷Lu-Lilotomab Satetraxetan in a First-in-Human Trial for Relapsed Indolent non-Hodgkin Lymphoma-Are We Hitting the Target?
Mol Imaging Biol, 24 (5), 807-817
DOI 10.1007/s11307-022-01731-3, PubMed 35486292

Høilund-Carlsen PF, Werner TJ, Alavi A, Revheim ME (2022)
Aducanumab-Related Amyloid-Related Imaging Abnormalities: Paean or Lament?
Clin Nucl Med, 47 (7), 625-626
DOI 10.1097/RLU.0000000000004250, PubMed 35452007

Alavi A, Werner TJ, Høilund-Carlsen PF, Revheim ME (2022)
Can Target-to-Background Ratio Measurement Lead to Detection and Accurate Quantification of Atherosclerosis With FDG PET? Likely Not
Clin Nucl Med, 47 (6), 532-536
DOI 10.1097/RLU.0000000000004131, PubMed 35384906

Müller EG, Edwin TH, Strand BH, Stokke C, Revheim ME, Knapskog AB (2022)
Is Amyloid Burden Measured by 18F-Flutemetamol PET Associated with Progression in Clinical Alzheimer's Disease?
J Alzheimers Dis, 85 (1), 197-205
DOI 10.3233/JAD-215046, PubMed 34776444

Høilund-Carlsen PF, Revheim ME, Alavi A (2022)
Alzheimer's Disease at a Crossroad: Time to Part from Amyloid to More Promising Aspects-Atherosclerosis for a Start
J Alzheimers Dis, 88 (2), 455-458
DOI 10.3233/JAD-220190, PubMed 35599491

Müller EG, Stokke C, Stokmo HL, Edwin TH, Knapskog AB, Revheim ME (2022)
Evaluation of semi-quantitative measures of ¹⁸F-flutemetamol PET for the clinical diagnosis of Alzheimer's disease
Quant Imaging Med Surg, 12 (1), 493-509
DOI 10.21037/qims-21-188, PubMed 34993096

Raynor WY, Park PSU, Borja AJ, Sun Y, Werner TJ, Ng SJ, Lau HC, Høilund-Carlsen PF, Alavi A, Revheim ME (2021)
PET-Based Imaging with ¹⁸F-FDG and ¹⁸F-NaF to Assess Inflammation and Microcalcification in Atherosclerosis and Other Vascular and Thrombotic Disorders
Diagnostics (Basel), 11 (12)
DOI 10.3390/diagnostics11122234, PubMed 34943473

Hole KH, Tulipan AJ, Reijnen JS, Hernes E, Vlatkovic L, Lie AK, Revheim ME, Seierstad T (2021)
Localization of primary prostate cancer: FACBC PET/CT compared with multiparametric MRI using histopathology as reference standard
Am J Nucl Med Mol Imaging, 11 (5), 387-394
PubMed 34754609

Jahangiri P, Dreyfuss AD, Duan F, Snyder BS, Borja AJ, Pournazari K, Kothekar E, Arani L, Al-Zaghal A, Seraj SM, Hancin EC, Pinheiro B, Werner TJ, Swisher-McClure S, Feigenberg SJ, Torigian DA, Revheim ME, Simone CB, Alavi A (2021)
Implementation of FDG-PET/CT imaging methodology for quantification of inflammatory response in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial
Am J Nucl Med Mol Imaging, 11 (5), 415-427
PubMed 34754612

Tulipan AJ, Salberg UB, Hole KH, Vlatkovic L, Aarnes EK, Revheim ME, Lyng H, Seierstad T (2021)
Amino acid transporter expression and 18F-FACBC uptake at PET in primary prostate cancer
Am J Nucl Med Mol Imaging, 11 (4), 250-259
PubMed 34513278

Revheim ME, Hole KH, Mo T, Bruland ØS, Reitan E, Julsrud L, Seierstad T (2021)
Multimodal functional imaging for early response assessment in patients with gastrointestinal stromal tumor treated with tyrosine kinase inhibitors
Acta Radiol, 63 (8), 995-1004
DOI 10.1177/02841851211027389, PubMed 34171968

Kaghazchi F, Borja AJ, Hancin EC, Bhattaru A, Detchou DKE, Seraj SM, Rojulpote C, Hess S, Nardo L, Gabriel PE, Damrauer SM, Werner TJ, Alavi A, Revheim ME (2021)
Venous thromboembolism detected by FDG-PET/CT in cancer patients: a common, yet life-threatening observation
Am J Nucl Med Mol Imaging, 11 (2), 99-106
PubMed 34079639

Ayubcha C, Raynor WY, Borja AJ, Seraj SM, Rojulpote C, Werner TJ, Revheim ME, Rajapakse CS, Alavi A (2021)
Magnetic resonance imaging-based partial volume-corrected 18F-sodium fluoride positron emission tomography in the femoral neck
Nucl Med Commun, 42 (4), 416-420
DOI 10.1097/MNM.0000000000001344, PubMed 33306627

Borja AJ, Hancin EC, Zhang V, Koa B, Bhattaru A, Rojulpote C, Detchou DK, Aly M, Kaghazchi F, Gerke O, Patil S, Gonuguntla K, Werner TJ, Revheim ME, Høilund-Carlsen PF, Alavi A (2021)
Global brain glucose uptake on 18F-FDG-PET/CT is influenced by chronic cardiovascular risk
Nucl Med Commun, 42 (4), 444-450
DOI 10.1097/MNM.0000000000001349, PubMed 33323870

Ayubcha C, Moghbel M, Borja AJ, Newberg A, Werner TJ, Alavi A, Revheim ME (2021)
Tau Imaging in Head Injury
PET Clin, 16 (2), 249-260
DOI 10.1016/j.cpet.2020.12.009, PubMed 33648666

Lynch C, Reguilon I, Langer DL, Lane D, De P, Wong WL, Mckiddie F, Ross A, Shack L, Win T, Marshall C, Revheim ME, Danckert B, Butler J, Dizdarevic S, Louzado C, Mcgivern C, Hazlett A, Chew C, O'connell M, Harrison S (2021)
A comparative analysis: international variation in PET-CT service provision in oncology-an International Cancer Benchmarking Partnership study
Int J Qual Health Care, 33 (1)
DOI 10.1093/intqhc/mzaa166, PubMed 33306102

Koa B, Borja AJ, Yellanki D, Rojulpote C, Tran J, Zhang V, Werner TJ, Alavi A, Revheim ME (2021)
¹⁸F-FDG-PET/CT in the assessment of atherosclerosis in lung cancer
Am J Nucl Med Mol Imaging, 11 (1), 1-9
PubMed 33688450

Hancin EC, Raynor WY, Borja AJ, Werner TJ, Revheim ME, Alavi A (2021)
Non-¹⁸F-FDG/¹⁸F-NaF Radiotracers Proposed for the Diagnosis and Management of Diseases of the Heart and Vasculature
PET Clin, 16 (2), 273-284
DOI 10.1016/j.cpet.2020.12.005, PubMed 33589388

Raynor WY, Borja AJ, Hancin EC, Werner TJ, Alavi A, Revheim ME (2021)
Novel Musculoskeletal and Orthopedic Applications of ¹⁸F-Sodium Fluoride PET
PET Clin, 16 (2), 295-311
DOI 10.1016/j.cpet.2020.12.006, PubMed 33589389

Fraz MSA, Moe N, Revheim ME, Stavrinou ML, Durheim MT, Nordøy I, Macpherson ME, Aukrust P, Jørgensen SF, Aaløkken TM, Fevang B (2021)
Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency-Features of CT and ¹⁸F-FDG Positron Emission Tomography/CT in Clinically Progressive Disease
Front Immunol, 11, 617985
DOI 10.3389/fimmu.2020.617985, PubMed 33584710

Arani LS, Zirakchian Zadeh M, Saboury B, Revheim ME, Øestergaard B, Borja AJ, Samadi Samarin D, Mehdizadeh Seraj S, Kalbush E, Ayubcha C, Morris MA, Werner TJ, Abildgaard N, Høilund-Carlsen PF, Alavi A (2021)
Assessment of atherosclerosis in multiple myeloma and smoldering myeloma patients using ¹⁸F- sodium fluoride PET/CT
J Nucl Cardiol, 28 (6), 3044-3054
DOI 10.1007/s12350-020-02446-0, PubMed 33389640

Koa B, Borja AJ, Yellanki D, Rojulpote C, Tran J, Zhang V, Werner TJ, Alavi A, Revheim ME (2021)
F-18-FDG-PET/CT in the assessment of atherosclerosis in lung cancer
Am. J. Nucl. Med. Molec. Imaging, 11 (1), 1-+

Johnsrud K, Seierstad T, Russell D, Revheim ME (2020)
Inter-reader agreement of ¹⁸F-FDG PET/CT for the quantification of carotid artery plaque inflammation
JRSM Cardiovasc Dis, 9, 2048004020980941
DOI 10.1177/2048004020980941, PubMed 33403110

Mouminah A, Borja AJ, Hancin EC, Chang YC, Werner TJ, Swisher-McClure S, Korostoff J, Alavi A, Revheim ME (2020)
¹⁸F-FDG-PET/CT in radiation therapy-induced parotid gland inflammation
Eur J Hybrid Imaging, 4 (1), 22
DOI 10.1186/s41824-020-00091-x, PubMed 34191165

Rogne AG, Müller EG, Udnaes E, Sigurdardottir S, Raudeberg R, Connelly JP, Revheim ME, Hassel B, Dahlberg D (2020)
β-Amyloid may accumulate in the human brain after focal bacterial infection: An ¹⁸ F-flutemetamol positron emission tomography study
Eur J Neurol, 28 (3), 877-883
DOI 10.1111/ene.14622, PubMed 33131195

Løndalen A, Blakkisrud J, Revheim ME, Madsbu UE, Dahle J, Kolstad A, Stokke C (2020)
FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of ¹⁷⁷Lu-lilotomab satetraxetan for treatment of relapsed non-Hodgkin lymphoma
Eur J Nucl Med Mol Imaging, 48 (6), 1902-1914
DOI 10.1007/s00259-020-05098-x, PubMed 33196921

Zirakchian Zadeh M, Raynor WY, Østergaard B, Hess S, Yellanki DP, Ayubcha C, Mehdizadeh Seraj S, Acosta-Montenegro O, Borja AJ, Gerke O, Werner TJ, Zhuang H, Revheim ME, Abildgaard N, Høilund-Carlsen PF, Alavi A (2020)
Correlation of whole-bone marrow dual-time-point ¹⁸F-FDG, as measured by a CT-based method of PET/CT quantification, with response to treatment in newly diagnosed multiple myeloma patients
Am J Nucl Med Mol Imaging, 10 (5), 257-264
PubMed 33224622

Kothekar E, Revheim ME, Borja AJ, Hancin EC, Detchou DK, Werner TJ, Shin DB, Gelfand JM, Alavi A (2020)
Utility of FDG-PET/CT in clinical psoriasis grading: the PET-PASI scoring system
Am J Nucl Med Mol Imaging, 10 (5), 265-271
PubMed 33224623

Paydary K, Revheim ME, Emamzadehfard S, Gholami S, Pourhassan S, Werner TJ, Høilund-Carlsen PF, Alavi A (2020)
Quantitative thoracic aorta calcification assessment by ¹⁸F-NaF PET/CT and its correlation with atherosclerotic cardiovascular disorders and increasing age
Eur Radiol, 31 (2), 785-794
DOI 10.1007/s00330-020-07133-9, PubMed 32870396

Zadeh MZ, Seraj SM, Østergaard B, Mimms S, Raynor WY, Aly M, Borja AJ, Arani LS, Gerke O, Werner TJ, Zhuang H, Revheim ME, Abildgaard N, Høilund-Carlsen PF, Alavi A (2020)
Prognostic significance of ¹⁸F-sodium fluoride in newly diagnosed multiple myeloma patients
Am J Nucl Med Mol Imaging, 10 (4), 151-160
PubMed 32929393

Zhang V, Koa B, Borja AJ, Padmanhabhan S, Bhattaru A, Raynor WY, Rojulpote C, Seraj SM, Werner TJ, Rajapakse C, Alavi A, Revheim ME (2020)
Diagnosis and Monitoring of Osteoporosis with Total-Body ¹⁸F-Sodium Fluoride-PET/CT
PET Clin, 15 (4), 487-496
DOI 10.1016/j.cpet.2020.06.011, PubMed 32768370

Zhang V, Borja AJ, Rojulpote C, Padmanabhan S, Patil S, Gonuguntla K, Revheim ME, Werner TJ, Høilund-Carlsen PF, Alavi A (2020)
Global quantification of pulmonary artery atherosclerosis using ¹⁸F-sodium fluoride PET/CT in at-risk subjects
Am J Nucl Med Mol Imaging, 10 (2), 119-126
PubMed 32419980

Seraj SM, Raynor WY, Revheim ME, Al-Zaghal A, Zadeh MZ, Arani LS, Rojulpote C, Werner TJ, Gerke O, Høilund-Carlsen PF, Baker JF, Alavi A, Hunt SJ (2020)
Assessing the feasibility of NaF-PET/CT versus FDG-PET/CT to detect abdominal aortic calcification or inflammation in rheumatoid arthritis patients
Ann Nucl Med, 34 (6), 424-431
DOI 10.1007/s12149-020-01463-w, PubMed 32277422

Zirakchian Zadeh M, Østergaard B, Raynor WY, Revheim ME, Seraj SM, Acosta-Montenegro O, Ayubcha C, Yellanki DP, Al-Zaghal A, Nielsen AL, Constantinescu CM, Gerke O, Werner TJ, Zhuang H, Abildgaard N, Høilund-Carlsen PF, Alavi A (2020)
Comparison of ¹⁸F-sodium fluoride uptake in the whole bone, pelvis, and femoral neck of multiple myeloma patients before and after high-dose therapy and conventional-dose chemotherapy
Eur J Nucl Med Mol Imaging, 47 (12), 2846-2855
DOI 10.1007/s00259-020-04768-0, PubMed 32246208

Pourhassan Shamchi S, Zirakchian Zadeh M, Østergaard B, Kim J, Raynor WY, Khosravi M, Taghvaei R, Nielsen AL, Gerke O, Werner TJ, Holdgaard P, Abildgaard N, Revheim ME, Høilund-Carlsen PF, Alavi A (2020)
Brain glucose metabolism in patients with newly diagnosed multiple myeloma significantly decreases after high-dose chemotherapy followed by autologous stem cell transplantation
Nucl Med Commun, 41 (3), 288-293
DOI 10.1097/MNM.0000000000001144, PubMed 31895757

Borja AJ, Hancin EC, Dreyfuss AD, Zhang V, Mathew T, Rojulpote C, Werner TJ, Patil S, Gonuguntla K, Lin A, Feigenberg SJ, Swisher-McClure S, Alavi A, Revheim ME (2020)
¹⁸F-FDG-PET/CT in the quantification of photon radiation therapy-induced vasculitis
Am J Nucl Med Mol Imaging, 10 (1), 66-73
PubMed 32211220

Kothekar E, Yellanki D, Borja AJ, Al-Zaghal A, Werner TJ, Revheim ME, Gerke O, Saboury B, Gholamrezanezad A, Høilund-Carlsen PF, Alavi A (2020)
18F-FDG-PET/CT in measuring volume and global metabolic activity of thigh muscles: a novel CT-based tissue segmentation methodology
Nucl Med Commun, 41 (2), 162-168
DOI 10.1097/MNM.0000000000001127, PubMed 31860525

Aksnes M, Müller EG, Tiiman A, Edwin TH, Terenius L, Revheim ME, Vukojević V, Bogdanović N, Knapskog AB (2020)
Amyloidogenic Nanoplaques in Cerebrospinal Fluid: Relationship to Amyloid Brain Uptake and Clinical Alzheimer's Disease in a Memory Clinic Cohort
J Alzheimers Dis, 77 (2), 831-842
DOI 10.3233/JAD-200237, PubMed 32741818

Borja AJ, Hancin EC, Dreyfuss AD, Zhang V, Mathew T, Rojulpote C, Werner TJ, Patil S, Gonuguntla K, Lin A, Feigenberg SJ, Swisher-McClure S, Alavi A, Revheim ME (2020)
F-18-FDG-PET/CT in the quantification of photon radiation therapy-induced vasculitis
Am. J. Nucl. Med. Molec. Imaging, 10 (1), 66-73

Zadeh MZ, Raynor WY, Ostergaard B, Hess S, Yellanki DP, Ayubcha C, Seraj SM, Acosta-Montenegro O, Borja AJ, Gerke O, Werner TJ, Zhuang HM, Revheim ME, Abildgaard N, Hoilund-Carlsen PF, Alavi A (2020)
Correlation of whole-bone marrow dual-time-point F-18-FDG, as measured by a CT-based method of PET/CT quantification, with response to treatment in newly diagnosed multiple myeloma patients
Am. J. Nucl. Med. Molec. Imaging, 10 (5), 257-264

Kothekar E, Borja AJ, Gerke O, Werner TJ, Alavi A, Revheim ME (2019)
Assessing respitatory muscle activity with ¹⁸F-FDG-PET/CT in patients with COPD
Am J Nucl Med Mol Imaging, 9 (6), 309-315
PubMed 31976160

Mirzaei S, Revheim ME, Raynor W, Zehetner W, Knoll P, Zandieh S, Alavi A (2019)
⁶⁴Cu-DOTATOC PET-CT in Patients with Neuroendocrine Tumors
Oncol Ther, 8 (1), 125-131
DOI 10.1007/s40487-019-00104-1, PubMed 32700066

Müller EG, Edwin TH, Stokke C, Navelsaker SS, Babovic A, Bogdanovic N, Knapskog AB, Revheim ME (2019)
Amyloid-β PET-Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic
PLoS One, 14 (8), e0221365
DOI 10.1371/journal.pone.0221365, PubMed 31430334

Tulipan AJ, Hole KH, Vlatkovic L, Revheim ME, Reijnen JS, Willoch F, Seierstad T, Lilleby W (2018)
Localization of radio-recurrence within the prostate: anti-3-18F-FACBC PET/CT compared with multiparametric MRI using histopathology as reference standard
Acta Radiol, 60 (8), 1028-1038
DOI 10.1177/0284185118810977, PubMed 30379559

Tulipan AJ, Vlatkovic L, Malinen E, Brennhovd B, Hole KH, Lie AK, Ragnum HB, Revheim ME, Seierstad T (2018)
Comparison of time curves from dynamic ¹⁸F-fluciclovine positron emission tomography and dynamic contrast-enhanced magnetic resonance imaging for primary prostate carcinomas
Phys Imaging Radiat Oncol, 7, 51-57
DOI 10.1016/j.phro.2018.09.003, PubMed 33458405

de Lange C, Solberg R, Holtedahl JE, Tulipan A, Barlinn J, Trigg W, Wickstrøm T, Saugstad OD, Malinen E, Revheim ME (2018)
Dynamic TSPO-PET for assessing early effects of cerebral hypoxia and resuscitation in new born pigs
Nucl Med Biol, 66, 49-57
DOI 10.1016/j.nucmedbio.2018.08.004, PubMed 30257223

Grut H, Revheim ME, Line PD, Dueland S (2018)
Importance of 18F-FDG PET/CT to select patients with nonresectable colorectal liver metastases for liver transplantation
Nucl Med Commun, 39 (7), 621-627
DOI 10.1097/MNM.0000000000000843, PubMed 29683930

Halsne T, Müller EG, Spiten AE, Sherwani AG, Gyland Mikalsen LT, Revheim ME, Stokke C (2018)
The Effect of New Formulas for Lean Body Mass on Lean-Body-Mass-Normalized SUV in Oncologic ¹⁸F-FDG PET/CT
J Nucl Med Technol, 46 (3), 253-259
DOI 10.2967/jnmt.117.204586, PubMed 29599401

Johnsrud K, Skagen K, Seierstad T, Skjelland M, Russell D, Revheim ME (2017)
¹⁸F-FDG PET/CT for the quantification of inflammation in large carotid artery plaques
J Nucl Cardiol, 26 (3), 883-893
DOI 10.1007/s12350-017-1121-7, PubMed 29209949

Grut H, Solberg S, Seierstad T, Revheim ME, Egge TS, Larsen SG, Line PD, Dueland S (2017)
Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases
Br J Surg, 105 (3), 295-301
DOI 10.1002/bjs.10651, PubMed 29168565

Grut H, Dueland S, Line PD, Revheim ME (2017)
The prognostic value of ¹⁸F-FDG PET/CT prior to liver transplantation for nonresectable colorectal liver metastases
Eur J Nucl Med Mol Imaging, 45 (2), 218-225
DOI 10.1007/s00259-017-3843-9, PubMed 29026950

Ausland L, Revheim ME, Skretting A, Stokke C (2017)
Respiratory motion during ⁹⁰Yttrium PET contributes to underestimation of tumor dose and overestimation of normal liver tissue dose
Acta Radiol, 59 (2), 132-139
DOI 10.1177/0284185117710052, PubMed 28509566

Lilleby W, Vlatkovic L, Meza-Zepeda LA, Revheim ME, Hovig E (2015)
Translocational renal cell carcinoma (t(6;11)(p21;q12) with transcription factor EB (TFEB) amplification and an integrated precision approach: a case report
J Med Case Rep, 9, 281
DOI 10.1186/s13256-015-0749-7, PubMed 26654961

Skagen K, Johnsrud K, Evensen K, Scott H, Krohg-Sørensen K, Reier-Nilsen F, Revheim ME, Fjeld JG, Skjelland M, Russell D (2015)
Carotid plaque inflammation assessed with (18)F-FDG PET/CT is higher in symptomatic compared with asymptomatic patients
Int J Stroke, 10 (5), 730-6
DOI 10.1111/ijs.12430, PubMed 25588553

Røe OD, Oppegaard PA, Revheim ME, Svindland A (2014)
Adrenocortical carcinoma mimicking lung cancer and responding to vinorelbine/carboplatin and pemetrexed/carboplatin
BMJ Case Rep, 2014
DOI 10.1136/bcr-2014-206225, PubMed 25391823

Revheim ME, Haugvik SP, Johnsrud K, Mathisen Ø, Fjeld JG, Skretting A (2014)
Respiratory gated and prolonged acquisition 18F-FDG PET improve preoperative assessment of colorectal liver metastases
Acta Radiol, 56 (4), 397-403
DOI 10.1177/0284185114529563, PubMed 24682406

Kristian A, Revheim ME, Qu H, Mælandsmo GM, Engebråten O, Seierstad T, Malinen E (2013)
Dynamic (18)F-FDG-PET for monitoring treatment effect following anti-angiogenic therapy in triple-negative breast cancer xenografts
Acta Oncol, 52 (7), 1566-72
DOI 10.3109/0284186X.2013.813634, PubMed 23984812

Kristian A, Nilsen LB, Røe K, Revheim ME, Engebråten O, Mælandsmo GM, Holm R, Malinen E, Seierstad T (2013)
Dynamic (18) F-FDG PET for Assessment of Tumor Physiology in Two Breast Carcinoma Xenografts
Nucl Med Mol Imaging, 47 (3), 173-80
DOI 10.1007/s13139-013-0211-y, PubMed 24900104

Skretting A, Revheim ME, Knudtsen IS, Johnsrud K, Bogsrud TV (2013)
An implementation of time-efficient respiratory-gated PET acquisition by repeated breath-holds
Acta Radiol, 54 (6), 672-5
DOI 10.1177/0284185113478007, PubMed 23463858

Revheim ME, Kristian A, Malinen E, Bruland ØS, Berner JM, Holm R, Joensuu H, Seierstad T (2013)
Intermittent and continuous imatinib in a human GIST xenograft model carrying KIT exon 17 resistance mutation D816H
Acta Oncol, 52 (4), 776-82
DOI 10.3109/0284186X.2013.770920, PubMed 23480638

Fløisand Y, Beiske K, Tjønnfjord GE, Heldal D, Bjerkehagen B, Revheim ME, Heim S, Bruland OS, Hall KS, Tierens A, Delabie J (2013)
Malignant phyllodes tumor and acute megakaryoblastic leukemia sharing a common clonal origin
Case Rep Hematol, 2013, 934781
DOI 10.1155/2013/934781, PubMed 24455338

Rusten E, Rødal J, Revheim ME, Skretting A, Bruland OS, Malinen E (2012)
Quantitative dynamic ¹⁸FDG-PET and tracer kinetic analysis of soft tissue sarcomas
Acta Oncol, 52 (6), 1160-7
DOI 10.3109/0284186X.2012.728713, PubMed 23198721

Revheim ME, Røe K, Bruland ØS, Bach-Gansmo T, Skretting A, Seierstad T (2011)
Monitoring the effect of targeted therapies in a gastrointestinal stromal tumor xenograft using a clinical PET/CT
Mol Imaging Biol, 13 (6), 1234-40
DOI 10.1007/s11307-010-0464-0, PubMed 21161686

Revheim ME, Winge-Main AK, Hagen G, Fjeld JG, Fosså SD, Lilleby W (2010)
Combined positron emission tomography/computed tomography in sunitinib therapy assessment of patients with metastatic renal cell carcinoma
Clin Oncol (R Coll Radiol), 23 (5), 339-43
DOI 10.1016/j.clon.2010.11.006, PubMed 21134733

Revheim ME, Seierstad T, Berner JM, Bruland OS, Røe K, Ohnstad HO, Bjerkehagen B, Bach-Gansmo T (2009)
Establishment and characterization of a human gastrointestinal stromal tumour (GIST) xenograft in athymic nude mice
Anticancer Res, 29 (11), 4331-6
PubMed 20032375

Review articles

Høilund-Carlsen PF, Alavi A, Castellani RJ, Neve RL, Perry G, Revheim ME, Barrio JR (2024)
Alzheimer's Amyloid Hypothesis and Antibody Therapy: Melting Glaciers?
Int J Mol Sci, 25 (7)
DOI 10.3390/ijms25073892, PubMed 38612701

Singh SB, Bhandari S, Bhandari S, Bhandari S, Singh R, Raynor WY, Hess S, Werner TJ, Alavi A, Revheim ME (2024)
Role of PET/CT in diagnosing and monitoring disease activity in rheumatoid arthritis: a review
Ann Nucl Med, 38 (3), 165-175
DOI 10.1007/s12149-023-01896-z, PubMed 38277115

Subtirelu RC, Teichner EM, Ashok A, Parikh C, Talasila S, Matache IM, Alnemri AG, Anderson V, Shahid O, Mannam S, Lee A, Werner T, Revheim ME, Alavi A (2023)
Advancements in dendritic cell vaccination: enhancing efficacy and optimizing combinatorial strategies for the treatment of glioblastoma
Front Neurol, 14, 1271822
DOI 10.3389/fneur.2023.1271822, PubMed 38020665

Puri T, Frost ML, Moore AEB, Choudhury A, Vinjamuri S, Mahajan A, Fynbo C, Vrist M, Theil J, Kairemo K, Wong J, Zaidi H, Revheim ME, Werner TJ, Alavi A, Cook GJR, Blake GM (2023)
Utility of a simplified [¹⁸F] sodium fluoride PET imaging method to quantify bone metabolic flux for a wide range of clinical applications
Front Endocrinol (Lausanne), 14, 1236881
DOI 10.3389/fendo.2023.1236881, PubMed 37780613

Talasila S, Teichner EM, Subtirelu RC, Xiang DH, Ayubcha C, Werner T, Alavi A, Revheim ME (2023)
The Role of FDG-PET in the Evaluation of Hidradenitis Suppurativa: A Systematic Review
J Clin Med, 12 (17)
DOI 10.3390/jcm12175491, PubMed 37685556

Hameed R, Bahadur AR, Singh SB, Sher J, Todua M, Moradi LM, Bastakoti S, Arslan M, Ajmal H, Lee GY, Ayubcha C, Werner TJ, Alavi A, Revheim ME (2023)
Neurological and Psychiatric Manifestations of Long COVID-19 and Their [¹⁸F]FDG PET Findings: A Review
Diagnostics (Basel), 13 (14)
DOI 10.3390/diagnostics13142353, PubMed 37510097

Høilund-Carlsen PF, Revheim ME, Costa T, Alavi A, Kepp KP, Sensi SL, Perry G, Robakis NK, Barrio JR, Vissel B (2023)
Passive Alzheimer's immunotherapy: A promising or uncertain option?
Ageing Res Rev, 90, 101996
DOI 10.1016/j.arr.2023.101996, PubMed 37414156

McDonald EO, Amanullah AA, Park PSU, Song W, Werner TJ, Alavi A, Revheim ME (2023)
The role of ¹⁸F-FDG PET/CT in primary cutaneous lymphoma: an educational review
Ann Nucl Med, 37 (6), 328-348
DOI 10.1007/s12149-023-01830-3, PubMed 37095393

Singh SB, Bhandari S, Siwakoti S, Bhatta R, Raynor WY, Werner TJ, Alavi A, Hess S, Revheim ME (2023)
Is Imaging Bacteria with PET a Realistic Option or an Illusion?
Diagnostics (Basel), 13 (7)
DOI 10.3390/diagnostics13071231, PubMed 37046449

Høilund-Carlsen PF, Piri R, Gerke O, Sturek M, Werner TJ, Revheim ME, Alavi A (2023)
NaF-PET Imaging of Atherosclerosis Burden
J Imaging, 9 (2)
DOI 10.3390/jimaging9020031, PubMed 36826950

Griffin MT, Werner TJ, Alavi A, Revheim ME (2023)
The value of FDG-PET/CT imaging in the assessment, monitoring, and management of COVID-19
Eur Phys J Plus, 138 (3), 283
DOI 10.1140/epjp/s13360-023-03797-6, PubMed 37008755

Koa B, Raynor WY, Park PSU, Borja AJ, Singhal S, Kuang A, Zhang V, Werner TJ, Alavi A, Revheim ME (2022)
Feasibility of Global Assessment of Bone Metastases in Prostate Cancer with ¹⁸F-Sodium Fluoride-PET/Computed Tomography
PET Clin, 17 (4), 631-640
DOI 10.1016/j.cpet.2022.07.007, PubMed 36229105

Raynor WY, Borja AJ, Zhang V, Kothekar E, Lau HC, Ng SJ, Seraj SM, Rojulpote C, Taghvaei R, Jin KY, Werner TJ, Høilund-Carlsen PF, Alavi A, Revheim ME (2022)
Assessing Coronary Artery and Aortic Calcification in Patients with Prostate Cancer Using ¹⁸F-Sodium Fluoride PET/Computed Tomography
PET Clin, 17 (4), 653-659
DOI 10.1016/j.cpet.2022.07.009, PubMed 36229106

Høilund-Carlsen PF, Piri R, Madsen PL, Revheim ME, Werner TJ, Alavi A, Gerke O, Sturek M (2022)
Atherosclerosis Burdens in Diabetes Mellitus: Assessment by PET Imaging
Int J Mol Sci, 23 (18)
DOI 10.3390/ijms231810268, PubMed 36142181

Borja AJ, Saini J, Raynor WY, Ayubcha C, Werner TJ, Alavi A, Revheim ME, Nagaraj C (2022)
Role of Molecular Imaging with PET/MR Imaging in the Diagnosis and Management of Brain Tumors
PET Clin, 17 (3), 431-451
DOI 10.1016/j.cpet.2022.03.002, PubMed 35662494

Helgebostad R, Revheim ME, Johnsrud K, Amlie K, Alavi A, Connelly JP (2022)
Clinical Applications of Somatostatin Receptor (Agonist) PET Tracers beyond Neuroendocrine Tumors
Diagnostics (Basel), 12 (2)
DOI 10.3390/diagnostics12020528, PubMed 35204618

Alavi A, Werner TJ, Raynor W, Høilund-Carlsen PF, Revheim ME (2021)
Critical review of PET imaging for detection and characterization of the atherosclerotic plaques with emphasis on limitations of FDG-PET compared to NaF-PET in this setting
Am J Nucl Med Mol Imaging, 11 (5), 337-351
PubMed 34754605

Rigney G, Ayubcha C, Werner TJ, Alavi A, Revheim ME (2021)
The utility of PET imaging in the diagnosis and management of psychosis: a brief review
Clin. Transl. Imaging
DOI 10.1007/s40336-021-00466-5

Seierstad T, Hole KH, Tulipan AJ, Strømme H, Lilleby W, Revheim ME, Hernes E (2021)
¹⁸F-Fluciclovine PET for Assessment of Prostate Cancer with Histopathology as Reference Standard: A Systematic Review
PET Clin, 16 (2), 167-176
DOI 10.1016/j.cpet.2020.12.012, PubMed 33648662

Hernes E, Revheim ME, Hole KH, Tulipan AJ, Strømme H, Lilleby W, Seierstad T (2021)
Prostate-Specific Membrane Antigen PET for Assessment of Primary and Recurrent Prostate Cancer with Histopathology as Reference Standard: A Systematic Review and Meta-Analysis
PET Clin, 16 (2), 147-165
DOI 10.1016/j.cpet.2020.12.001, PubMed 33648661

Koa B, Borja AJ, Aly M, Padmanabhan S, Tran J, Zhang V, Rojulpote C, Pierson SK, Tamakloe MA, Khor JS, Werner TJ, Fajgenbaum DC, Alavi A, Revheim ME (2021)
Emerging role of 18F-FDG PET/CT in Castleman disease: a review
Insights Imaging, 12 (1), 35
DOI 10.1186/s13244-021-00963-1, PubMed 33709329

Borja AJ, Hancin EC, Raynor WY, Ayubcha C, Detchou DK, Werner TJ, Revheim ME, Alavi A (2021)
A Critical Review of PET Tracers Used for Brain Tumor Imaging
PET Clin, 16 (2), 219-231
DOI 10.1016/j.cpet.2020.12.004, PubMed 33589386

Mayer M, Borja AJ, Hancin EC, Auslander T, Revheim ME, Moghbel MC, Werner TJ, Alavi A, Rajapakse CS (2020)
Imaging Atherosclerosis by PET, With Emphasis on the Role of FDG and NaF as Potential Biomarkers for This Disorder
Front Physiol, 11, 511391
DOI 10.3389/fphys.2020.511391, PubMed 33192540

Ayubcha C, Revheim ME, Newberg A, Moghbel M, Rojulpote C, Werner TJ, Alavi A (2020)
A critical review of radiotracers in the positron emission tomography imaging of traumatic brain injury: FDG, tau, and amyloid imaging in mild traumatic brain injury and chronic traumatic encephalopathy
Eur J Nucl Med Mol Imaging, 48 (2), 623-641
DOI 10.1007/s00259-020-04926-4, PubMed 32696090

Hompland I, Hølmebakk T, Boye K, Stoldt S, Bjerkehagen B, Berner JM, Wiedswang AM, Revheim ME, Poulsen JP, Hall KS, Bruland ØS (2018)
[Not Available]
Tidsskr Nor Laegeforen, 138 (15)
DOI 10.4045/tidsskr.18.0200, PubMed 30277049